Answers are grounded in this paper and cite their sources.
SARS-CoV-2 infection can cause severe pneumonia (COVID-19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In the present report, we first describe two cases of persisting SARS-CoV-2 viraemia with fatal outcome in patients after rituximab therapy.
No takes yet. Share an insight, caveat, or question.
Tepasse et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: